This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Marchesi, F. Articles by Allavena, P. Search for Related Content PubMed PubMed Citation Articles by Marchesi, F. Articles by Allavena, P.

The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma

Departments of ¹ Immunology and Inflammation, ² Pathology, and ³ Gastroenterology, IRCCS Clinical Institute Humanitas, Rozzano, Milano, Italy; ⁴ Diabetes Research Institute and Departments of ⁵ Pathology, ⁶ Oncology, and ⁷ Surgery, IRCCS San Raffaele Scientific Institute; ⁸ Department of Neuroscience, Mario Negri Institute; and ⁹ Department of Pathology and ¹⁰ Institute of Pathology, University of Milan, Milan, Italy

Requests for reprints: Paola Allavena, Istituto Clinico Humanitas, via Manzoni 56, 20089 Rozzano (MI), Italy. Phone: 39-02-82245112; Fax: 39-02-82245101; E-mail: paola.allavena{at}humanitas.it.

Key Words: CX3CR1 • neurotropism • pancreatic cancer

Tumor perineural dissemination is a hallmark of human pancreatic ductal adenocarcinoma (PDAC) and represents a major source of local tumor recurrence after surgery. In this study, we provide in vitro and in vivo evidence that the chemokine receptor CX3CR1 may be involved in the neurotropism of PDAC cells to local peripheral nerves. Neoplastic cells from PDAC cell lines and surgical specimens express the chemokine receptor CX3CR1, absent in normal pancreatic ducts. Its unique ligand, the transmembrane chemokine CX3CL1, is expressed by neurons and nerve fibers. CX3CR1 + PDAC cell lines migrated in response to human recombinant CX3CL1 and specifically adhered to CX3CL1-expressing cells of neural origin via mechanisms involving activation of G proteins, β1 integrins, and focal adhesion kinase. In vivo experiments with transplanted PDAC showed that only CX3CR1-transfected tumor cells infiltrated the local peripheral nerves. Immunohistochemistry of CX3CR1 in PDAC specimens revealed that 90% of the samples were positive with a heterogeneous pattern of expression. High receptor score was significantly associated with more prominent tumor perineural infiltration evaluated histologically (P = 0.026). Regression analyses (univariate and multivariate) showed that high CX3CR1 expression and perineural invasion were strongly associated with local and earlier tumor recurrence (P = 0.007). Collectively, this study shows that the CX3CR1 receptor may be involved in PDAC tumor neurotropism and is a relevant and independent risk factor to predict an early local tumor relapse in resected patients. Thus, the CX3CR1-CX3CL1 axis could represent a valuable therapeutic target to prevent tumor perineural dissemination in pancreatic cancer. [Cancer Res 2008;68(21):9060–9]